Ci-1040 drug page Clinical trials

Trials with Ci-1040

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
1Countries
172Planned patients
All 2 Finished 2

Showing 1–2 of 2

CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer
Finished Phase 2 NCT00033384

RATIONALE: CI-1040 may stop the growth of tumors by blocking the enzymes necessary for cancer cell growth and by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of CI-1040 in treating patients who have…

United States Feb 2002 – Nov 2003 Interventional
See the trial ClinicalTrials.gov Am I eligible?
A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer
Finished Phase 2 172 patients NCT00034827

CI-1040 is an experimental drug that is being tested in patients who have advanced colorectal and lung cancer who failed no more than one prior chemotherapy regimen, breast cancer who have failed no more than 2 prior regimens and in patien…

United States Jan 2002 – May 2003 Interventional
See the trial ClinicalTrials.gov Am I eligible?